Louise Roulin

Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Large B-cell lymphoma: The LYSA pragmatic guidelines.

Large B-cell lymphoma: The LYSA pragmatic guidelines.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 21, 2025

Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group.

Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group.

Journal: Blood advances

Published: June 02, 2025

Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.

Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.

Journal: Blood advances

Published: April 16, 2025

Anti-CD19 CAR T-cell therapy for patients with Richter transformation: A LYSA study from the DESCAR-T registry.

Anti-CD19 CAR T-cell therapy for patients with Richter transformation: A LYSA study from the DESCAR-T registry.

Journal: British journal of haematology

Published: January 27, 2025

TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas.

TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas.

Journal: Blood advances

Published: January 07, 2025

Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study.

Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study.

Journal: Blood advances

Published: September 19, 2024

Short-term neurological tolerance of chimeric antigen receptor-T cell therapy for refractory B-cell malignancy in patients with pre-existing cognitive impairment: A retrospective cohort study.

Short-term neurological tolerance of chimeric antigen receptor-T cell therapy for refractory B-cell malignancy in patients with pre-existing cognitive impairment: A retrospective cohort study.

Journal: Journal of geriatric oncology

Published: August 07, 2024

Combined daratumumab-pomalidomide and ultra-fractionated whole breast irradiation is safe!

Combined daratumumab-pomalidomide and ultra-fractionated whole breast irradiation is safe!

Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Published: December 13, 2023

Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study.

Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study.

Journal: ESC heart failure

Published: July 18, 2023

Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France.

Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France.

Journal: Archives of cardiovascular diseases

Published: February 13, 2023

Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort.

Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort.

Journal: British journal of haematology

Published: January 16, 2023

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.

Journal: Haematologica

Published: November 08, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026